Clinical characteristics and related risk factors of depression in patients with early COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018
Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
CPAP and measures of cardiovascular risks in patients with OSAS Source: Eur Respir J 2009; 33: 1520 Year: 2009
Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Evaluation of polysomnographic data in OSAS patients with cardiac diseases Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea Year: 2009
Preliminary results of relationship between appetite and clinical presentation of COPD patients in AERIS study Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015
The relationship of comorbidities with clinical and phsyiological parameters in COPD Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021
Clinical phenotypes and characteristics in patients with OSAS and nocturnal respiratory failure Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021
Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007
Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021
Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020
Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Baseline characteristics of severe asthma patients initiating biologic treatment worldwide Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
OSAS and the incidence of cardiovascular disorders Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
A new proposal for OSA classification in children based on cardiovascular outcome Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012
PROactive COPD, towards a patient reported outcome capturing physical activity in COPD Source: Annual Congress 2009 - EU Research Programmes. IMI: 1. U-BIOPRED asthma 2. PROactive COPD Year: 2009
LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013
Study of microalbuminuria in COPD patients and its association with cardiac comorbidities Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021